We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Honey-Based Dressings Promote Wound Healing

By HospiMedica staff writers
Posted on 27 Nov 2007
Novel wound dressings that are based on active manuka (Leptospermum scoparium) honey encourage effective lesion healing.

The Medihoney wound & burn dressings are indicated for use on wounds with light to moderate exudates. More...
A hydrocolloid based dressing forms a gel when it comes into contact with wound fluid to assist in promoting a moist environment conducive to healing. A second, alginate based dressing is indicated for wounds with moderate to heavy levels of exudates.

The new dressings, both in adhesive and non-adhesive versions, have been shown to lower the pH level of wounds, which helps to create a more optimal environment for wound healing; when wound pH is lowered, protease modulation and increased oxygen diffusion take place, both beneficial to hard-to-heal wounds. Additionally, the dressings--due to their high levels of glucose and other sugars--have been shown to promote a strong osmotic effect. This osmotic effect, drawing fluid from surrounding tissues, helps to constantly bathe wounds in lymph fluid, which assists in the removal of necrotic tissue, slough, and debris from the wound bed. The dressings are products of Derma Sciences (Toronto, Canada), manufactured under license from Comvita (Te Puke, New Zealand).

"Ultimately, we intend to offer clinicians a complete line of dressings based on the patented honey-based wound dressing technologies,” said Edward J. Quilty, Derma Science CEO.

L. scoparium (Manuka or Tea tree) is a shrub native to New Zealand and southeast Australia. It is not as yet fully understood why only some manuka honey has an antimicrobial property. The presence of this activity can be detected by laboratory testing and if verified is referred to as "active”.


Related Links:
Derma Sciences
Comvita

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.